Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
BCR-JAK2 fusion
i
Other names:
BCR, BCR Activator Of RhoGEF And GTPase, BCR, RhoGEF And GTPase Activating Protein, Breakpoint Cluster Region Protein, Renal Carcinoma Antigen NY-REN-26, Breakpoint Cluster Region, D22S11, BCR1, BCR/FGFR1 Chimera Protein, FGFR1/BCR Chimera Protein, D22S662, ALL, CML, PHL, JTK10, THCYT3, JAK2, Janus Kinase 2, Tyrosine-Protein Kinase JAK2, JAK-2
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
613
;
3717
Related biomarkers:
Expression
Mutation
CNA
Fusion
Others
‹
JAK2 mutation (4)
JAK2 V617F (4)
JAK2 F547 (2)
BCR-ABL1 A337T (1)
BCR-ABL1 P465S (1)
BCR-ABL1 Q252H + BCR-ABL1 V299L (1)
BCR-ABL1 T315L (1)
BCR-ABL1 Y253H + BCR-ABL1 T315I (1)
JAK2 F694L (1)
JAK2 mutation + CRLF2 rearrangement (1)
JAK2 R683G (1)
JAK2 R938Q (1)
JAK2 rearrangement (1)
JAK2 I682F (0)
JAK2 QGinsR683 (0)
JAK2 R867Q (0)
JAK2 rearrangement (0)
JAK2 mutation (4)
JAK2 V617F (4)
JAK2 F547 (2)
BCR-ABL1 A337T (1)
BCR-ABL1 P465S (1)
BCR-ABL1 Q252H + BCR-ABL1 V299L (1)
BCR-ABL1 T315L (1)
BCR-ABL1 Y253H + BCR-ABL1 T315I (1)
JAK2 F694L (1)
JAK2 mutation + CRLF2 rearrangement (1)
JAK2 R683G (1)
JAK2 R938Q (1)
JAK2 rearrangement (1)
JAK2 I682F (0)
JAK2 QGinsR683 (0)
JAK2 R867Q (0)
JAK2 rearrangement (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
BCR-JAK2 fusion
Acute Lymphocytic Leukemia
BCR-JAK2 fusion
Acute Lymphocytic Leukemia
ruxolitinib
Sensitive: D – Preclinical
ruxolitinib
Sensitive
:
D
ruxolitinib
Sensitive: D – Preclinical
ruxolitinib
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.